Clinical trial
Exploratory Study of Gastric Cancer Organoids in the Screening of Neoadjuvant Chemotherapy and Immunotherapy Drugs
NCT06196554 is registered in ClinicalTrials.gov with Dong Bing Zhao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Study of Gastric Cancer Organoids in the Screening of Neoadjuvant Chemotherapy and Immunotherapy Drugs
- Lead sponsor
- Dong Bing Zhao
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2023
- Completion date
- June 28, 2024
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer, neoadjuvant therapy, organoid